Information:
Error:
ID
12654
Description
Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL); ODM derived from: https://clinicaltrials.gov/show/NCT00130195
Link
https://clinicaltrials.gov/show/NCT00130195
Keywords
Versions (1)
- 08-12-15 08-12-15 -
Uploaded on
8 december 2015
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Acute Lymphoblastic Leukemia NCT00130195
Eligibility Acute Lymphoblastic Leukemia NCT00130195
- StudyEvent: Eligibility
Similar models
Eligibility Acute Lymphoblastic Leukemia NCT00130195
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
age, hct
Item
adult subjects with a hct of less than 30 or pediatric subjects less than 25 will be excluded.
boolean
C0001779 (UMLS CUI [1])
C0518014 (UMLS CUI [2])
C0518014 (UMLS CUI [2])
age
Item
children with hcv infection younger than 2 years of age will be excluded.
boolean
C0001779 (UMLS CUI [1])
age
Item
unaffected healthy volunteers who are minors are not eligible for this study.
boolean
C0001779 (UMLS CUI [1])